Takeda: all 1,753 studies

Page 9 of 18. Open to participants first (93), then studies with results posted, then the rest; newest registration first within each.

• Long-term Safety of SPD422 in Japanese Adults With Essential ThrombocythaemiaCompletedNCT01467661Phase 3Results posted
• Assess the Safety and Pharmacokinetics of Ascending, Multiple Oral Doses of SPD489 in Adults With SchizophreniaCompletedNCT01457339Phase 1Results posted
• Comparison of TAK-875 (Fasiglifam) With Placebo in Participants With Type 2 DiabetesCompletedNCT01456195Phase 3Results posted
• A Study to Evaluate the Effectiveness and Safety of a Fixed Dose Combination of Azilsartan Medoxomil and Chlorthalidone in Patients With High Blood Pressure Who do Not Achieve Target Blood Pressure Following Treatment With Azilsartan Medoxomil AloneCompletedNCT01456169Phase 3Results posted
• Long-term Study of Alogliptin as an Add-on to Rapid-Acting Insulin Secretagogues in Type 2 DiabetesCompletedNCT01456130Phase 3Results posted
• A Study to Investigate the Safety and Tolerability of NPSP558, for the Treatment of Adults With Hypoparathyroidism - A Clinical Extension Study in HungaryCompletedNCT01455181Phase 3Results posted
• Pharmacokinetics Study of Oral IXAZOMIB in Participants With Advanced Nonhematologic Malignancies or LymphomaCompletedNCT01454076Phase 1Results posted
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-Tumor Activity of the Oral Anaplastic Lymphoma Kinase (ALK)/Epidermal Growth Factor Receptor (EGFR) Inhibitor Brigatinib (AP26113)CompletedNCT01449461Phase 1/2Results posted
• Dose Escalation Study of TAK-117 (MLN1117) in Subjects With Advanced CancerCompletedNCT01449370Phase 1Results posted
• Collection and Study of Cerebrospinal Fluid in Patients With Hunter SyndromeCompletedNCT01449240Results posted
• Amoxicillin Drug Interaction Study With MMX® Mesalazine/MesalamineCompletedNCT01442688Phase 1Results posted
• SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension StudyTerminatedNCT01436175Phase 3Results posted
• Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive DisorderCompletedNCT01436162Phase 3Results posted
• Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive DisorderCompletedNCT01436149Phase 3Results posted
• SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive DisorderCompletedNCT01435759Phase 2Results posted
• Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Congenital Hemophilia ATerminatedNCT01434511Phase 3Results posted
• A Clinical Trial With Intranasal Fentanyl in Cancer Patients With Breakthrough PainCompletedNCT01429051Phase 3Results posted
• A Study to Evaluate the Safety and Pharmacology of Subcutaneous Administration of CINRYZE With Recombinant Human HyaluronidaseCompletedNCT01426763Phase 2Results posted
• Study of MLN2480 in Participants With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion in Participants With Metastatic MelanomaCompletedNCT01425008Phase 1Results posted
• Evaluation of Long-term Prucalopride Treatment With Chronic Constipation in Subjects Aged ≥ 18 YearsCompletedNCT01424228Phase 4Results posted
• Safety and Efficacy Study of SAR 1118 to Treat Dry Eye Conducted in a Controlled Adverse Environment (CAE) (OPUS-1)CompletedNCT01421498Phase 3Results posted
• Metronidazole Drug Interaction Study With MMX® Mesalazine/MesalamineCompletedNCT01418365Phase 1Results posted
• SSP-002358 Drug Interaction Study With OmeprazoleCompletedNCT01415349Phase 1Results posted
• Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)CompletedNCT01410227Phase 3Results posted
• Ciprofloxacin XR Drug Interaction Study With MMX® Mesalazine/MesalamineCompletedNCT01402947Phase 1Results posted
• MLN8237 in Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma Treated With Rituximab +/- VincristineCompletedNCT01397825Phase 1/2Results posted
• Pharmacokinetics and Pharmacodynamics Study of Alogliptin in Healthy Korean ParticipantsCompletedNCT01391663Phase 1Results posted
• Evaluate PF-00547659 On Cerebrospinal Fluid Lymphocytes In Volunteers With Crohn's Disease Or Ulcerative Colitis Who Failed Or Did Not Tolerate Anti-TNFsCompletedNCT01387594Phase 1Results posted
• A Pharmacokinetic, Tolerability and Safety Study of Icatibant in Children and Adolescents With Hereditary AngioedemaCompletedNCT01386658Phase 3Results posted
• Study of Oral IXAZOMIB in Combination With Lenalidomide and Dexamethasone in Participants With Newly Diagnosed Multiple MyelomaCompletedNCT01383928Phase 1/2Results posted
• Early Prophylaxis Immunologic Challenge (EPIC) StudyTerminatedNCT01376700Phase 3Results posted
• An Explorative Trial to Evaluate the Pharmacodynamic Effect of SPD557 on Reflux Parameters in Refractory GERD PatientsTerminatedNCT01370863Phase 2Results posted
• Vortioxetine (Lu AA21004) 10 and 20 mg for Treatment of Major Depressive Disorder With Sexual DysfunctionCompletedNCT01364649Phase 3Results posted
• Safety, Efficacy and Pharmacokinetics of an Oral Iron Chelator Given for a Year to Pediatric Patients With Iron OverloadTerminatedNCT01363908Phase 2Results posted
• Safety Study of Replagal® Therapy in Children With Fabry DiseaseCompletedNCT01363492Phase 2Results posted
• TASALL - TachoSil® Against Liquor LeakCompletedNCT01355627Phase 3Results posted
• Efficacy Study of Vortioxetine (Lu AA21004) for Treatment of Major Depressive DisorderCompletedNCT01355081Phase 3Results posted
• Exploratory Multi-centre Trial In Patients With ET Treated With XAGRID®CompletedNCT01352585Results posted
• Dose Escalation Study of MLN0128 in Combination With Paclitaxel, With/Without Trastuzumab, in Subjects With Advanced Solid MalignanciesCompletedNCT01351350Phase 1Results posted
• Long-term Efficacy and Safety Study of TAK-085 in Participants With HypertriglyceridemiaCompletedNCT01350999Phase 3Results posted
• Efficacy of TAK-085 in Participants With HypertriglyceridemiaCompletedNCT01350973Phase 3Results posted
• Evaluation of Ecallantide for Treatment of Angiotensin Converting Enzyme (ACE) Inhibitor Induced AngioedemaTerminatedNCT01343823Phase 2Results posted
• Study of Oral Ixazomib in Combination With Melphalan and Prednisone in Participants With Newly Diagnosed Multiple MyelomaCompletedNCT01335685Phase 1/2Results posted
• Prucalopride in Pediatric Subjects With Functional ConstipationCompletedNCT01330381Phase 3Results posted
• Lisdexamfetamine Dimesylate 2-year Safety Study in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)CompletedNCT01328756Phase 4Results posted
• Study of Oral Ixazomib in Adult Participants With Relapsed or Refractory Light Chain AmyloidosisCompletedNCT01318902Phase 1Results posted
• Long-term Safety Study of Alogliptin Used in Combination With Sulfonylurea or Metformin in Participants With Type 2 Diabetes in JapanCompletedNCT01318135Phase 2/3Results posted
• Long-term Safety Study of Alogliptin Used in Combination With Thiazolidine in Participants With Type 2 Diabetes in JapanCompletedNCT01318122Phase 2/3Results posted
• Efficacy and Safety of Alogliptin Used Combination With Metformin in Participants With Type 2 Diabetes in JapanCompletedNCT01318109Phase 2/3Results posted
• Efficacy and Safety of Alogliptin Used in Combination With Sulfonylurea in Participants With Type 2 Diabetes in JapanCompletedNCT01318083Phase 2/3Results posted
• Efficacy and Safety of Alogliptin Used Combination With Thiazolidine in Participants With Type 2 Diabetes in JapanCompletedNCT01318070Phase 2/3Results posted
• A Trial to Evaluate the Safety and Tolerability of Namilumab (MT203) in Patients With Mild to Moderate Rheumatoid ArthritisCompletedNCT01317797Phase 1Results posted
• Long-Term Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Hypertension and Kidney DiseaseCompletedNCT01309828Phase 3Results posted
• This Study is Designed to Evaluate PD/PK and Safety of Replagal Manufactured by Two Different Processes.CompletedNCT01304277Phase 2Results posted
• Effects of Vortioxetine (Lu AA21004) on the Concentrations of Selected Neurotransmitters in Healthy Male AdultsCompletedNCT01299805Phase 1Results posted
• Extension of Study HGT-SAN-055 Evaluating Administration of rhHNS in Patients With Sanfilippo Syndrome Type A (MPS IIIA)TerminatedNCT01299727Phase 1/2Results posted
• A Study To Monitor Long-Term Treatment With PF-00547659CompletedNCT01298492Phase 2Results posted
• A Multicenter Open-Label Treatment Protocol to Observe the Safety of Replagal (Agalsidase Alfa) Enzyme Replacement Therapy in Canadian Patients With Fabry DiseaseCompletedNCT01298141Phase 3Results posted
• A Open-label Study Investigating the Safety and Tolerability of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH [1-84]), for the Treatment of Adults With Hypoparathyroidism - A Clinical Extension Study (RACE)CompletedNCT01297309Phase 3Results posted
• Forced-dose Titration of SPD489 in Adults With Binge Eating DisorderCompletedNCT01291173Phase 2Results posted
• Efficacy and Safety of Alogliptin in Participants With Type 2 DiabetesCompletedNCT01289119Phase 3Results posted
• BAX 326 (rFIX) Continuation StudyCompletedNCT01286779Phase 3Results posted
• Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's DiseaseCompletedNCT01276509Phase 2Results posted
• Study of Safety and Efficacy of a rhPTH[1-84] of Fixed Doses of 25 and 50 mcg in Adults With Hypoparathyroidism (RELAY)CompletedNCT01268098Phase 3Results posted
• Long-term Safety Study of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in JapanCompletedNCT01263509Phase 2/3Results posted
• Long-term Safety Study of Alogliptin in Participants With Type 2 Diabetes in JapanCompletedNCT01263496Phase 2Results posted
• Efficacy and Safety of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in JapanCompletedNCT01263483Phase 2/3Results posted
• Efficacy and Safety of Alogliptin in Participants With Type 2 Diabetes in JapanCompletedNCT01263470Phase 2Results posted
• Safety and Efficacy Study of VP20621 for Prevention of Recurrent Clostridium Difficile InfectionCompletedNCT01259726Phase 2Results posted
• Efficacy and Safety Study of Vortioxetine (Lu AA21004) for Treatment of Major Depressive DisorderCompletedNCT01255787Phase 2/3Results posted
• Efficacy and Safety of Extended-release Guanfacine Hydrochloride in Children and Adolescents Aged 6-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)CompletedNCT01244490Phase 3Results posted
• Co-Administration of LDX (SPD489) and Venlafaxine XR (EFFEXOR XR) in Healthy VolunteersCompletedNCT01235338Phase 1Results posted
• Study of Vedolizumab in Patients With Moderate to Severe Crohn's DiseaseCompletedNCT01224171Phase 3Results posted
• Phase 2/3 Study of IGSC, 20% in PIDDCompletedNCT01218438Phase 2/3Results posted
• A Study of Ixazomib Administered in Combination With Lenalidomide and Low-Dose Dexamethasone in Patients With Newly Diagnosed Multiple MyelomaCompletedNCT01217957Phase 1/2Results posted
• Effect of Dexlansoprazole on Bone HomeostasisCompletedNCT01216293Phase 1Results posted
• Effect of SPD422 on Platelet Lowering and Safety in Japanese Adults With At Risk Essential ThrombocythaemiaCompletedNCT01214915Phase 3Results posted
• Ponatinib for Chronic Myeloid Leukemia (CML) Evaluation and Ph+ Acute Lymphoblastic Leukemia (ALL)CompletedNCT01207440Phase 2Results posted
• Study Comparing Orteronel Plus Prednisone in Participants With Metastatic Castration-Resistant Prostate Cancer.CompletedNCT01193257Phase 3Results posted
• Study Comparing Orteronel Plus Prednisone in Participants With Chemotherapy-Naive Metastatic Castration-Resistant Prostate CancerCompletedNCT01193244Phase 3Results posted
• French Observational Xagrid (FOX) Study In Adult Patients With Essential ThrombocythemiaCompletedNCT01192347Results posted
• TachoSil® Versus Surgicel® Original for the Secondary Treatment of Local Bleeding in Adult and Pediatric Patients Undergoing Hepatic Resection SurgeryCompletedNCT01192022Phase 3Results posted
• Safety and Pharmacodynamic Study of an Oral Iron Chelator Given for 6 Months to Patients With Iron OverloadCompletedNCT01186419Phase 2Results posted
• SPD544 High Strength Bioequivalence StudyCompletedNCT01183234Phase 1Results posted
• Safety and Efficacy Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive DisorderCompletedNCT01179516Phase 3Results posted
• Study of Orally Administered TAK-960 in Patients With Advanced Nonhematologic MalignanciesTerminatedNCT01179399Phase 1Results posted
• Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Acquired Hemophilia ACompletedNCT01178294Phase 2/3Results posted
• Study of Vedolizumab Following Multiple Intravenous Doses in Patients With Ulcerative ColitisCompletedNCT01177228Phase 2Results posted
• Tolerability and Safety of Immune Globulin Subcutaneous Solution (IGSC) and rHuPH20 in PIDCompletedNCT01175213Phase 3Results posted
• Pivotal Study (Pharmacokinetics, Efficacy, Safety) of BAX 326 (rFIX) in Hemophilia B PatientsCompletedNCT01174446Phase 3Results posted
• Bivalent Norovirus Vaccine StudyCompletedNCT01168401Phase 1Results posted
• Efficacy and Safety Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive DisorderCompletedNCT01163266Phase 3Results posted
• Safety, Tolerability, Ascending Dose and Dose Frequency Study of rhHNS Via an IDDD in MPS IIIA PatientsCompletedNCT01155778Phase 1/2Results posted
• Safety and Efficacy of Vortioxetine (Lu AA21004) in Adults With Major Depressive DisorderCompletedNCT01153009Phase 3Results posted
• Safety and Tolerability of Vortioxetine (LuAA21004) - Open Label Extension StudyCompletedNCT01152996Phase 3Results posted
• Evaluation of Prucalopride in Male Subjects With Chronic Constipation.CompletedNCT01147926Phase 3Results posted
• A Pilot Study to Evaluate the Use of C1 Esterase Inhibitor (Human) in Patients With Acute Antibody-Mediated RejectionCompletedNCT01147302Phase 2Results posted
• Safety and Efficacy of Lansoprazole in Patients With Reflux DiseaseCompletedNCT01135368Phase 4Results posted
• Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative ColitisCompletedNCT01130844Phase 1Results posted
• Effect of Lanthanum Carbonate in Patients Previously Treated With Calcium-based Phosphate Binder TherapyCompletedNCT01130831Results posted

← Takeda overview and focus areas